Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Expert Review of Hematology|November 7, 2014
Design of the INHIBIT trial: preventing inhibitors by avoiding 'danger', prolonging half-life and promoting toleranceMargaret V Ragni, Lynn M MalecJournal of Pediatric Hematology/Oncology|July 24, 2014
Three cost-utility analyses of screening for intracranial hemorrhage in neonates with hemophiliaLynn M Malec, Robert F Sidonio, Kenneth J Smith, et al.Journal of Pediatric Gastroenterology and Nutrition|November 15, 2017
Prophylactic rtPA in the Prevention of Line-associated Thrombosis and Infection in Short Bowel SyndromeLynn M Malec, James Cooper, Jeffrey Rudolph, et al.Pediatric Blood & Cancer|January 10, 2017
Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care centerChristine M Leeper, Madhav Vissa, James D Cooper, et al.Thrombosis Research|July 13, 2020
Observational study of recombinant factor VIII-Fc, rFVIIIFc, in hemophilia APatrick T Ebbert, Frederico Xavier, Lynn M Malec, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|November 11, 2021
Bleeding patterns in patients before and after diagnosis of von Willebrand disease: Analysis of a US medical claims databaseJonathan C Roberts, Lynn M Malec, Imrran Halari, et al.Blood|June 10, 2025
The T follicular helper/T follicular helper regulatory pathway in FVIII immune responses in miceWeiqing Jing, Jocelyn A Schroeder, Saurabh Kumar, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|April 18, 2019
Regional variation and cost implications of prescribed extended half-life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophiliaStacy E Croteau, Dunlei Cheng, Alice J Cohen, et al.American Journal of Hematology|May 2, 2020
The impact of extended half-life factor concentrates on prophylaxis for severe hemophilia in the United StatesLynn M Malec, Dunlei Cheng, Char M Witmer, et al.Thrombosis Research|June 4, 2017
Feasibility of the Von Willebrand disease PREVENT trialMargaret V Ragni, Nicoletta Machin, Andra H James, et al.Pageof 2